Figure 4. Kaplan–Meier analysis of OS and RFS in ICC according to integrated analysis of CD86+/CD206+ TAMs.
(A) OS for integrated analysis of CD86+/CD206+ TAMs in 322 ICC patients and (B) RFS for integrated analysis of CD86+/CD206+ TAMs in 322 ICC patients. Group I, high immunostaining density of CD86+ but low CD206+ TAMs; Group II, both low immunostaining density of CD86+ and CD206+ TAMs; Group III, both high immunostaining density of CD86+ and CD206+ TAMs; Group IV, low immunostaining density of CD86+ but high CD206+ TAMs. p Values were calculated by log-rank test, and p < 0.05 was considered statistically significant. OS, Overall survival; RFS, recurrence-free survival.